Delivery Order SPE2DB25D3017-SPE2DB25FVKUD
- Not listed
- The Defense Logistics Agency awarded a $1,452.88 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Menquadfi vial 0.5ml, a meningococcal vaccine product. The contract was competitively awarded with no set-aside designation and is scheduled for completion by August 12, 2025. AmerisourceBergen will perform work from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor serving...
- The Defense Logistics Agency awarded a $2,823.27 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of MENQUADFI vial 0.5ML, a meningococcal vaccine product. The delivery order, which is non-set-aside and competitively awarded, is scheduled for completion by July 29, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $15,255.24 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Menquadfi vial 0.5ML, a meningococcal vaccine product. The delivery order, which represents a child contract action under a larger vehicle, is scheduled for completion by August 19, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation,...
- On July 29, 2025, the Defense Logistics Agency (DLA) awarded a delivery order valued at $1,452.88 to AmerisourceBergen Drug Corp for the supply of Menquadfi vial 0.5ML, a meningococcal vaccine product. The contract is a firm fixed-price delivery order with an ultimate completion date of July 30, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation. The delivery order is a...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $7,990.84 by the Defense Logistics Agency's Medical Supply Chain on August 20, 2025, with an ultimate completion date of August 21, 2025. The contract, designated as a firm fixed-price delivery order without set-aside, covers the supply of Menquadfi vials (0.5mL), a meningococcal vaccine product. This award is issued as a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at approximately $1,392 to Amerisourcebergen Drug Corporation for MENQUADFI vaccine vials. To be performed in Conshohocken, Pennsylvania under firm fixed price terms, the order calls for 4562210524 doses of the 0.5ml vials from September 18 to September 19, 2023. As a leading provider of medical supplies and pharmaceuticals to the Department of Defense, Amerisourcebergen will deliver the meningococcal vaccines in support of the...
- The Defense Logistics Agency awarded a $237,587.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Menveo 1 vial (meningococcal conjugate vaccine) with completion targeted for August 27, 2025. This non-set-aside award, issued on August 26, 2025, represents a single delivery order fulfillment from AmerisourceBergen's larger contract vehicle with DLA. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $21,401.45 to AmerisourceBergen Drug Corp for the supply of Menquadfi vials (0.5ML) on September 10, 2025, with an ultimate completion date of September 11, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a $4,383.44 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Menveo 1 Vial (A-C-Y-W-135-DIP) 0.5ML, a meningococcal conjugate vaccine. The contract has an ultimate completion date of September 19, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this award, indicating it was competitively awarded. As a...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $13,397.27 on August 12, 2025, for the supply of Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine. This firm fixed price delivery order, with an ultimate completion date of August 13, 2025, carries no set-aside designation and represents a competitively awarded transaction. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- SPE2DB25D3017Indefinite Delivery Contract
- SPE2DB25D3017-SPE2DB25FVKUDDelivery Order
The Defense Logistics Agency awarded a $20,340.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Menquadfi vial 0.5ml, a meningococcal vaccine. The award, with an ultimate completion date of September 24, 2025, was competitively awarded with no set-aside designation. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026, which serves as the comprehensive global pharmaceutical support vehicle enabling the company to supply medications and medical supplies to military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, maintains extensive federal contracting relationships with the Defense Logistics Agency Medical Supply Chain. The company's federal portfolio demonstrates significant capability in delivering brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to support military and veteran healthcare systems. The rapid completion timeline for this vaccine delivery reflects the critical nature of medical supply chain operations within the Department of Defense, where AmerisourceBergen serves as a trusted vendor for the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $20.3k | 9/23/25 |